# Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

> clinical trial · VERIFIED · 2026-07-10

Status: RECRUITING · Sponsor: University Hospital, Clermont-Ferrand · Condition: Hereditary Hemorrhagic Telangiectasia

- Company: University Hospital, Clermont-Ferrand
- Sector: Hereditary Hemorrhagic Telangiectasia
- Primary source: https://clinicaltrials.gov/study/NCT05641142

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.